| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IDXX | Common Stock | Options Exercise | $679K | +10K | +38% | $67.85 | 36.3K | Nov 8, 2021 | Direct | F1 |
| transaction | IDXX | Common Stock | Sale | -$813K | -1.3K | -3.58% | $625.25 | 35K | Nov 8, 2021 | Direct | F2 |
| transaction | IDXX | Common Stock | Sale | -$689K | -1.1K | -3.14% | $626.47 | 33.9K | Nov 8, 2021 | Direct | F3 |
| transaction | IDXX | Common Stock | Sale | -$832K | -1.33K | -3.91% | $627.41 | 32.6K | Nov 8, 2021 | Direct | F4 |
| transaction | IDXX | Common Stock | Sale | -$1.48M | -2.36K | -7.23% | $628.19 | 30.2K | Nov 8, 2021 | Direct | F5 |
| transaction | IDXX | Common Stock | Sale | -$1.32M | -2.09K | -6.93% | $629.63 | 28.1K | Nov 8, 2021 | Direct | F6 |
| transaction | IDXX | Common Stock | Sale | -$612K | -971 | -3.45% | $630.39 | 27.2K | Nov 8, 2021 | Direct | F7 |
| transaction | IDXX | Common Stock | Sale | -$469K | -743 | -2.73% | $631.39 | 26.4K | Nov 8, 2021 | Direct | F8 |
| transaction | IDXX | Common Stock | Sale | -$69.5K | -110 | -0.42% | $632.19 | 26.3K | Nov 8, 2021 | Direct | F9 |
| transaction | IDXX | Common Stock | Options Exercise | $428K | +6.31K | +23.98% | $67.85 | 32.6K | Nov 9, 2021 | Direct | |
| transaction | IDXX | Common Stock | Sale | -$3.59M | -5.7K | -17.48% | $630.13 | 26.9K | Nov 9, 2021 | Direct | F10 |
| transaction | IDXX | Common Stock | Sale | -$383K | -607 | -2.25% | $631.01 | 26.3K | Nov 9, 2021 | Direct | F11 |
| holding | IDXX | Common Stock | 18.1K | Nov 8, 2021 | by Estony McKeon Family, LLC |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IDXX | Non-Qualified Stock Option (right-to-buy) | Options Exercise | -10K | -21.96% | 35.5K | Nov 8, 2021 | Common Stock | 10K | $67.85 | Direct | F12, F13 | ||
| transaction | IDXX | Non-Qualified Stock Option (right-to-buy) | Options Exercise | -6.31K | -17.76% | 29.2K | Nov 9, 2021 | Common Stock | 6.31K | $67.85 | Direct | F12, F13 |
| Id | Content |
|---|---|
| F1 | Includes 9 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on September 30, 2021. |
| F2 | This transaction was executed in multiple trades at prices ranging from $625.00 to $625.65. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F3 | This transaction was executed in multiple trades at prices ranging from $626.10 to $627.005. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F4 | This transaction was executed in multiple trades at prices ranging from $627.07 to $628.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F5 | This transaction was executed in multiple trades at prices ranging from $628.01 to $628.98. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F6 | This transaction was executed in multiple trades at prices ranging from $629.10 to $629.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F7 | This transaction was executed in multiple trades at prices ranging from $630.03 to $630.98. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F8 | This transaction was executed in multiple trades at prices ranging from $631.10 to $631.65. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F9 | This transaction was executed in multiple trades at prices ranging from $632.01 to $632.36. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F10 | This transaction was executed in multiple trades at prices ranging from $630.00 to $631.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F11 | This transaction was executed in multiple trades at prices ranging from $631.005 to $631.49. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F12 | Grant of option to buy 45,535 shares of IDEXX Laboratories, Inc. common stock that vested in five annual installments beginning February 14, 2017. |
| F13 | Not applicable. |